General Information of Drug (ID: DMD6CLG)

Drug Name
TZP-201 Drug Info
Synonyms
JTZ-2002; IBS-D therapeutic, Tranzyme; Irritable bowel syndrome (diarrhea type) therapeutic, Tranzyme; Motilin antagonists (IBS/ fuctional dyspepsia), Tranzyme; Motilin receptor antagonists (irritable bowel syndrome/ functional dyspepsia), Tranzyme; Motilin receptor antagonists (irritable bowel syndrome/diarrhea), Tranzyme
Indication
Disease Entry ICD 11 Status REF
Diarrhea ME05.1 Investigative [1]
Cross-matching ID
TTD Drug ID
DMD6CLG

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Drug(s) Targeting Motilin receptor (MLNR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
MOTILIN DMVILAD N. A. N. A. Phase 4 [2]
Camicinal DMAKSMX Delayed gastric emptying DA41.00 Phase 2 [1]
Mitemcinal fumarate DMOJ7QA Pain MG30-MG3Z Phase 2 [3]
RWJ-68023 DM4O07Q Irritable bowel syndrome DD91.0 Phase 1 [4]
KOS-2187 DM4953W Gastroesophageal reflux disease DA22.Z Phase 1 [5]
DS-3801 DM6WN9X Constipation DD91.1 Phase 1 [6]
GSK-1322888 DMNYGB8 Gastroparesis DA41.00 Phase 1 [7]
KW-5139 DMLOKXI Pain MG30-MG3Z Discontinued in Phase 2 [8]
KC-11458 DMOITN2 Gastric motility disorder DA21 Discontinued in Phase 2 [9]
SLV-305 DMBZM0D Gastric motility disorder DA21 Discontinued in Phase 2 [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Motilin receptor (MLNR) TT953CX MTLR_HUMAN Antagonist [1]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 297).
2 Discovery of a new class of macrocyclic antagonists to the human motilin receptor. J Med Chem. 2006 Nov 30;49(24):7190-7.
3 Clinical pipeline report, company report or official report of Roche (2009).
4 Effects of a nonpeptide motilin receptor antagonist on proximal gastric motor function. Br J Clin Pharmacol. 2004 Apr;57(4):393-401.
5 Kosan Announces Selection of KOS-2187 As Motilide Clinical Candidate at World Congress of Gastroenterology Meeting. Kosan. 2006.
6 Clinical pipeline report, company report or official report of Daiichi Sankyo.
7 ClinicalTrials.gov (NCT01294566) FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers. U.S. National Institutes of Health.
8 Stimulating action of KW-5139 (Leu13-motilin) on gastrointestinal motility in the rabbit. Br J Pharmacol. 1994 Jan;111(1):288-94.
9 Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis. Aliment Pharmacol Ther. 2004 Aug 1;20(3):333-8.